The anti-TNFR1 Nb TROS was shown to inhibit inflammation in vitro and in vivo (137), TROS also reduced neuroinflammation, preserved myelin and neurons in the MS model (mog35-55 induced experimental autoimmune encephalomyelitis, EAE) (138). Here, TNFRSF1A is linked to myeloid sarcoma.